The abstract is read at the publisher; the summary is JClub's.
In 100 p16-positive, HPV DNA-positive oropharyngeal squamous cell carcinomas, strictly episomal HPV16_A1 tumors showed 0 progression events versus 23.1% cumulative incidence at 60 months with integration and/or viral SV.
- Why it matters: Even among generally favorable HPV-positive OPSCC, some patients recur, and clinicians lack dependable viral genomic biomarkers to stratify recurrence risk.
- What they did: Targeted viral capture sequencing profiled HPV genotype, sublineage, single-nucleotide variation, integration sites, viral structural variants, clonality, and viral copy number in two independent cohorts, then tested associations with progression, PFS, and overall survival at 60 months.
- The result: Within HPV16_A1, integration and/or SV defined a higher-risk group, while high-risk single-nucleotide variants and a novel upstream regulatory region variant were linked to worse PFS; integration sites clustered in open chromatin near E2 and E4 genes.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.